Human Anti-GCGR scFv-Fc Chimera (VS-0425-FY112)
CAT#: VS-0425-FY112
This fusion protein targets GCGR (Glucagon receptor), a receptor involved in glucose and lipid metabolism. By inhibiting GCGR, it can modulate glucagon signaling and has potential applications in treating diabetes and other metabolic disorders.
Gene Expression
Subcellular Location
Figure 1 IF staining of human cell line U-2 OS
Immunofluorescent staining of human cell line U-2 OS shows localization to the Golgi apparatus.
* Image credit: Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/71228/1338_A11_7_selected.jpg
RNA Expression
Figure 2 RNA cell line category: Cell line enhanced (HeLa, MCF7, SK-BR-3, U-87 MG)
Cell lines ordered by descending RNA expression order.
* Image credit: Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000215644-GCGR
❮
❯
Specifications
- Immunogen
- The immunogen was the human glucagon receptor expressed on cells.
- Host Species
- Human
- Type
- Human IgG1, scFv-Fc
- Specificity
- Human GCGR
- Species Reactivity
- Human
- Applications
- Inhibition
- Related Disease
- Metabolic Disorders (Not Specified); Hyperglycemic Agents; Type 2 Diabetes
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Shipping
- Ice packs
Applications
- Application Notes
- The optimal dilution concentration is determined by the experiment.
Target
- Alternative Names
- Glucagon Receptor; GL-R; GGR
- Gene ID
- 2642
- UniProt ID
- P47871
- Long Name
- Glucagon Receptor
- Sequence Similarities
- Belongs to the G-protein coupled receptor 2 family.
- Cellular Localization
- Cell membrane
- Post Translation Modifications
- Ligand-binding promotes phosphorylation of serine residues in the C-terminal cytoplasmic domain.
Phosphorylation is important for receptor endocytosis after ligand-binding.
Glycosylation at Asn46, Asn59, Asn74, and Asn78
Modification sites at PhosphoSitePlus
Glycosylation from GlyGen 4 sites
- Protein Refseq
- XP_006722340.1; XP_011521841.1; XP_016879935.1; XP_054171686.1; XP_054171687.1
- Function
- G-protein coupled receptor for glucagon that plays a central role in the regulation of blood glucose levels and glucose homeostasis.
Regulates the rate of hepatic glucose production by promoting glycogen hydrolysis and gluconeogenesis.
Plays an important role in mediating the responses to fasting.
Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase.
Promotes activation of adenylate cyclase.
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for VS-0425-FY112. Click the button above to contact us or submit your feedback about this product.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "GCGR"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-1786z | Mouse Anti-GCGR Recombinant Antibody (clone 40C5) | WB, ELISA | Mouse IgG1, κ |
| HPAB-0023-LS | Mouse Anti-GCGR Recombinant Antibody (clone 6.23V3) | WB, FC, FuncS | Mouse IgG1 κ |
| HPAB-0138-FY | Human Anti-GCGR Recombinant Antibody (HPAB-0138-FY) | Block | Human IgG4, κ |
| HPAB-0105LY | Human Anti-GCGR Recombinant Antibody (HPAB-0105LY) | ELISA | Human IgG |
| HPAB-3045LY | Human Anti-GCGR Recombinant Antibody (HPAB-3045LY) | ELISA | Human IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PFBW-048 | Mouse Anti-GCGR Recombinant Antibody (clone HGR-2 F6); Fab Fragment | Block | Mouse Fab |
| PFBL-477 | Recombinant Human Anti-GCGR Antibody Fab Fragment (PFBL-477) | WB, ELISA, FuncS | Fab |
| HPAB-1620LY-F(E) | Human Anti-GCGR Recombinant Antibody (clone CBL034); Fab Fragment | ELISA, IHC | Human Fab |
| HPAB-1621LY-F(E) | Human Anti-GCGR Recombinant Antibody (clone CBL035); Fab Fragment | ELISA, IHC | Human Fab |
| HPAB-0105LY-F(E) | Human Anti-GCGR Recombinant Antibody; Fab Fragment (HPAB-0105LY-F(E)) | ELISA | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| PSBW-048 | Mouse Anti-GCGR Recombinant Antibody (clone HGR-2 F6); scFv Fragment | Block | Mouse scFv |
| PSBL-477 | Recombinant Human Anti-GCGR Antibody scFv Fragment (PSBL-477) | WB, ELISA, FuncS | scFv |
| HPAB-0023-LS-F(E) | Mouse Anti-GCGR Recombinant Antibody (clone 6.23V3); Fab Fragment | WB, FC | Mouse Fab |
| HPAB-0138-FY-S(P) | Human Anti-GCGR Recombinant Antibody; scFv Fragment (HPAB-0138-FY-S(P)) | Block | Human scFv |
| HPAB-3385LY-S(P) | Human Anti-GCGR Recombinant Antibody (clone CBL150); scFv Fragment | ELISA | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-063CQ | Anti-Human GCGR Recombinant Antibody (mAb5) | ELISA, FC | |
| TAB-064CQ | Anti-Human GCGR Recombinant Antibody (3C7) | ELISA, FC, WB | |
| TAB-067CQ | Mouse Anti-GCGR Recombinant Antibody (TAB-067CQ) | ELISA, FC | Mouse IgG |
| PABX-067 | Recombinant Mouse Anti-GR-2 Antibody (F6) | WB, Neut, FuncS | IgG |
| PABX-067-F (E) | Recombinant Mouse Anti-GR-2 Antibody Fab Fragment (F6) | WB, Neut, FuncS | Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-065CQ | Anti-Human GCGR Recombinant Antibody (H6.23v3) | ELISA, FC, WB | Human antibody |
| TAB-068CQ | Human Anti-GCGR Recombinant Antibody (TAB-068CQ) | ELISA, FC | Human IgG2 |
| TAB-065CQ-S(P) | Anti-Human GCGR Recombinant Antibody scFv Fragment (H6.23v3) | ELISA, FC, WB | Human antibody |
| TAB-068CQ-S(P) | Human Anti-GCGR Recombinant Antibody; scFv Fragment (TAB-068CQ-S(P)) | ELISA, FC | Human scFv |
| TAB-069CQ-S(P) | Human Anti-GCGR Recombinant Antibody; scFv Fragment (TAB-069CQ-S(P)) | ELISA, FC | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-066CQ | Anti-Human GCGR Recombinant Antibody (3C7v11) | ELISA, FC, WB | Humanized antibody |
| TAB-066CQ-S(P) | Anti-Human GCGR Recombinant Antibody scFv Fragment (3C7v11) | ELISA, FC, WB | Humanized antibody |
| TAB-066CQ-F(E) | Anti-Human GCGR Recombinant Antibody Fab Fragment (3C7v11) | ELISA, FC, WB | Humanized antibody |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| Gly-113LC | Recombinant Anti-Human GCGR Antibody (Fc glycosylation) | ELISA | Chimeric antibody (mouse/human) |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| VS-0425-YC385 | Recombinant Anti-GCGR Vesicular Antibody, EV Displayed (VS-0425-YC385) | ELISA, FC, Neut, Cell-uptake |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: ELISA, WB, BLI, SPR
Application: ELISA
-2.png)
Application: WB, ELISA, FC, IHC, IP
Application: Neut, FC
Application: FC, ADCC, CDC, Inhib
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, FC, IHC, IF, IP
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
